Calix Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 5.15 M
- Paid Up Capital ₹ 5.15 M
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 10.77 Cr
- Satisfied Charges ₹ 2.70 Cr
- Revenue Growth 21.88%
- Profit Growth 15.74%
- Ebitda 68.77%
- Net Worth 98.59%
- Total Assets 68.69%
About Calix Life Sciences
Calix Life Sciences Private Limited (CLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 14 August 2012 and has a history of 12 years and five months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 5.15 M and a paid-up capital of Rs 5.15 M.
The company currently has active open charges totaling ₹10.77 Cr. The company has closed loans amounting to ₹2.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunil Chandore, Aashwiin Pardessi, and Vijay Apte serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U36912PN2012PTC144371
-
Company No.
144371
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Aug 2012
-
Date of AGM
30 Sep 2016
-
Date of Balance Sheet
31 Mar 2016
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Calix Life Sciences?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vijay Apte | Director | 14-Aug-2012 | Current |
Aashwiin Pardessi | Director | 14-Aug-2012 | Current |
Sunil Chandore | Director | 14-Aug-2012 | Current |
Financial Performance of Calix Life Sciences.
Calix Life Sciences Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 21.88% increase. The company also saw a substantial improvement in profitability, with a 15.74% increase in profit. The company's net worth Soared by an impressive increase of 98.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Calix Life Sciences?
In 2016, Calix Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹107.72 M
₹27.00 M
Charges Breakdown by Lending Institutions
- The South Indian Bank Limited : 4.67 Cr
- Others : 3.50 Cr
- Nkgsb Co-Operative Bank : 2.60 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
18 Aug 2017 | The South Indian Bank Limited | ₹4.67 Cr | Open |
04 Feb 2017 | Others | ₹3.50 Cr | Open |
02 Sep 2015 | Nkgsb Co-Operative Bank | ₹1.00 Cr | Open |
02 Sep 2015 | Nkgsb Co-Operative Bank | ₹1.60 Cr | Open |
04 Mar 2015 | City Union Bank Limited | ₹1.10 Cr | Satisfied |
How Many Employees Work at Calix Life Sciences?
Calix Life Sciences has a workforce of 18 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Calix Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Calix Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.